Clinical Trials Browser

Phase 1 × Unknown × Neurofibromatoses × Clear all

NCT05107037 2021-11-04

A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of TQ-B3234 in Patients With Type I Neurofibromatosis

Phase 1 Unknown

Neurofibromatoses